Brief: Lavipharm 9-Month Net Profit At EUR 2.1 Million, Down 21.6% YoY
08/11/2023 15:51
Nov 8 (Reuters) - Lavipharm SA LPHr.AT :
* 9-MONTH SALES BEFORE CLAWBACK AND REBATES EUR 45.9 MILLION
VERSUS EUR 37.9 MILLION YEAR AGO
* 9-MONTH ADJUSTED EBITDA EUR 7.5 MILLION VERSUS EUR 5.4
MILLION
YEAR AGO
* 9-MONTH NET PROFIT EUR 2.1 MILLION VERSUS EUR 2.7 MILLION
YEAR
AGO
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY